Physician profile
Christopher Lee
NPI 1235647512
$906.32
in general payments reported to CMS, 2019-2025
9 companies · $380 in 2025
The $380 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $78.89 · 2023: $32.94 · 2024: $415 · 2025: $380.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $684 · Education: $144.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $683.53 |
| Education | $143.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $183.41 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Heartflow, INC. | $168.30 | 2025 | |
| Abbott Laboratories | $143.90 | 2024 | Ensite |
| Genzyme Corporation | $119.70 | 2025 | |
| Cvrx, INC. | $87.42 | 2024 | Barostim Neo System |
| Convatec INC. | $82.13 | 2022-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $54.41 | 2025 | Lifevest |
| Atricure, INC. | $37.35 | 2025 | Atriclip Laa Exclusion System |
| Stryker Corporation | $29.70 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.